Osaic Holdings’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.55K | Buy |
3,650
+1,445
| +66% | +$2.2K | ﹤0.01% | 6063 |
|
|
2025
Q1 | $1.74K | Sell |
2,205
-1,105
| -33% | -$872 | ﹤0.01% | 6517 |
|
|
2024
Q4 | $5.46K | Buy |
3,310
+98
| +3% | +$162 | ﹤0.01% | 6046 |
|
|
2024
Q3 | $11.2K | Sell |
3,212
-1,712
| -35% | -$5.99K | ﹤0.01% | 5682 |
|
|
2024
Q2 | $16.2K | Sell |
4,924
-31
| -0.6% | -$102 | ﹤0.01% | 5435 |
|
|
2024
Q1 | $36.4K | Buy |
4,955
+102
| +2% | +$749 | ﹤0.01% | 4938 |
|
|
2023
Q4 | $18.1K | Sell |
4,853
-236
| -5% | -$883 | ﹤0.01% | 5526 |
|
|
2023
Q3 | $10.8K | Sell |
5,089
-1,256
| -20% | -$2.66K | ﹤0.01% | 5843 |
|
|
2023
Q2 | $30.3K | Sell |
6,345
-219
| -3% | -$1.04K | ﹤0.01% | 5272 |
|
|
2023
Q1 | $37.3K | Buy |
6,564
+193
| +3% | +$1.1K | ﹤0.01% | 5145 |
|
|
2022
Q4 | $63.2K | Buy |
6,371
+5,344
| +520% | +$53K | ﹤0.01% | 4754 |
|
|
2022
Q3 | $22K | Buy |
1,027
+216
| +27% | +$4.63K | ﹤0.01% | 5499 |
|
|
2022
Q2 | $20K | Sell |
811
-204
| -20% | -$5.03K | ﹤0.01% | 5590 |
|
|
2022
Q1 | $401K | Buy |
1,015
+3
| +0.3% | +$1.19K | ﹤0.01% | 3428 |
|
|
2021
Q4 | $61K | Sell |
1,012
-565
| -36% | -$34.1K | ﹤0.01% | 4989 |
|
|
2021
Q3 | $94K | Sell |
1,577
-2,092
| -57% | -$125K | ﹤0.01% | 4579 |
|
|
2021
Q2 | $320K | Buy |
3,669
+2,619
| +249% | +$228K | ﹤0.01% | 3451 |
|
|
2021
Q1 | $87K | Sell |
1,050
-676
| -39% | -$56K | ﹤0.01% | 4453 |
|
|
2020
Q4 | $158K | Sell |
1,726
-3,692
| -68% | -$338K | ﹤0.01% | 3679 |
|
|
2020
Q3 | $197K | Buy |
5,418
+484
| +10% | +$17.6K | ﹤0.01% | 3269 |
|
|
2020
Q2 | $169K | Buy |
4,934
+71
| +1% | +$2.43K | ﹤0.01% | 3277 |
|
|
2020
Q1 | $117K | Buy |
+4,863
| New | +$117K | ﹤0.01% | 3337 |
|